MedPath

The New York State Psychiatric Institute

The New York State Psychiatric Institute logo
🇺🇸United States
Ownership
Private
Established
1895-01-01
Employees
251
Market Cap
-
Website
http://www.nyspi.org

Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder

Phase 2
Completed
Conditions
Marijuana Abuse
Attention Deficit Disorder With Hyperactivity
Interventions
Other: placebo
First Posted Date
2005-09-02
Last Posted Date
2019-04-23
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
2
Registration Number
NCT00142961
Locations
🇺🇸

Phoenix House, New York, New York, United States

Levetiracetam for the Treatment of Alcohol Dependence and Anxiety

Phase 2
Completed
Conditions
Generalized Anxiety Disorder
Panic Disorder
Social Phobia
Alcoholism
Anxiety Disorders
Interventions
First Posted Date
2005-09-01
Last Posted Date
2019-04-24
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
3
Registration Number
NCT00141115
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Effect of Smoking Exposure on Smoking Relapse Following Brief Abstinence - 2

Not Applicable
Completed
Conditions
Tobacco Use Disorder
Interventions
Behavioral: Neutral or active cigarette cues
First Posted Date
2005-08-29
Last Posted Date
2018-06-18
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
12
Registration Number
NCT00136838
Locations
🇺🇸

Columbia University, New York, New York, United States

Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3

Phase 1
Completed
Conditions
Tobacco Use Disorder
Interventions
First Posted Date
2005-08-29
Last Posted Date
2018-05-21
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
25
Registration Number
NCT00136786
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

The Effects of Memantine and Bupropion on Acute, Reinforcing, and Conditioned Effects of Cigarettes - 1

Phase 1
Completed
Conditions
Tobacco Use Disorder
Interventions
First Posted Date
2005-08-29
Last Posted Date
2018-05-21
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
45
Registration Number
NCT00136747
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Methylphenidate Treatment for Cocaine Abuse and ADHD - 1

Phase 1
Completed
Conditions
Cocaine-Related Disorders
Attention Deficit Disorder With Hyperactivity
Interventions
Other: placebo
First Posted Date
2005-08-29
Last Posted Date
2019-04-23
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
124
Registration Number
NCT00136734
Locations
🇺🇸

Research Foundation for Mental Hygiene, Inc., New York, New York, United States

Effectiveness of Memantine in Treating Cocaine-Dependent Individuals - 2

Phase 2
Completed
Conditions
Cocaine-Related Disorders
Interventions
Drug: placebo
First Posted Date
2005-08-25
Last Posted Date
2019-04-24
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
81
Registration Number
NCT00134901
Locations
🇺🇸

Research Foundation for Mental Hygiene, Inc., New York, New York, United States

Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1

Phase 2
Completed
Conditions
Depression
Marijuana Abuse
Interventions
Drug: Placebo
First Posted Date
2005-08-18
Last Posted Date
2019-04-24
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
123
Registration Number
NCT00131456
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Memantine and Naltrexone Treatment for Opioid Dependence

Phase 2
Completed
Conditions
Opioid Dependence
Interventions
First Posted Date
2005-08-01
Last Posted Date
2018-06-18
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
81
Registration Number
NCT00125515
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Effectiveness of Modafinil for Treating Fatigue in Adults With HIV/AIDS

Phase 4
Completed
Conditions
HIV Infections
Fatigue
Interventions
Drug: Placebo
First Posted Date
2005-07-11
Last Posted Date
2017-05-10
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
115
Registration Number
NCT00118378
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath